Prostate Cancer Research - Symptoms, Genetics, Screening, Treatment, Information

Prostate Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Prostate Cancer, including details on symptoms, genetics, screening, treatment, information.


Prostate Cancer Research Today

Home

View Latest Issue

Information About Prostate Cancer

Books on Prostate Cancer

Advertising in Research Today

View Other Research Today Publications



Volume 3 (2006), Issue 2 (February)

  1. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
    Nucleic Acids Res, 34(2): 734-44. [Abstract] [Full-text]
  2. Regulation of prostate cell collagen receptors by malignant transformation.
    Int J Cancer, 118(4): 889-98. [Abstract] [Full-text]
  3. Enhancing the antitumor activity of ErbB blockade with histone deacetylase (HDAC) inhibition.
    Int J Cancer, 118(4): 1041-50. [Abstract] [Full-text]
  4. Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressiveness.
    Int J Cancer, 118(4): 850-6. [Abstract] [Full-text]
  5. Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells.
    Int J Cancer, 118(4): 1022-31. [Abstract] [Full-text]
  6. Differential expression of TGFbeta-stimulated clone 22 in normal prostate and prostate cancer.
    Int J Cancer, 118(4): 899-906. [Abstract] [Full-text]
  7. Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patients with prostate cancer.
    Int J Cancer, 118(4): 1051-3. [Abstract] [Full-text]
  8. Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment.
    BMC Cancer, 6: 15. [Abstract] [Full-text]
  9. Influence of number of CAG repeats on local control in the RTOG 86-10 protocol.
    Am J Clin Oncol, 29(1): 14-20. [Abstract] [Full-text]
  10. Tolerance of endorectal balloon in 396 patients treated with intensity-modulated radiation therapy (IMRT) for prostate cancer.
    Am J Clin Oncol, 29(1): 8-11. [Abstract] [Full-text]
  11. Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway.
    Cell, 124(3): 615-29. [Abstract] [Full-text]
  12. Combination of methylated-DNA precipitation and methylation-sensitive restriction enzymes (COMPARE-MS) for the rapid, sensitive and quantitative detection of DNA methylation.
    Nucleic Acids Res, 34(3): e19. [Abstract] [Full-text]
  13. Sensitization to gimatecan-induced apoptosis by tumor necrosis factor-related apoptosis inducing ligand in prostate carcinoma cells.
    Biochem Pharmacol, 71(6): 791-8. [Abstract] [Full-text]
  14. Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells.
    Biochem Pharmacol, 71(6): 751-60. [Abstract] [Full-text]
  15. TRB3 is a PI 3-kinase dependent indicator for nutrient starvation.
    Cell Signal, 18(6): 899-909. [Abstract] [Full-text]
  16. Gene promoter methylation in prostate tumor-associated stromal cells.
    J Natl Cancer Inst, 98(4): 255-61. [Abstract] [Full-text]
  17. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk.
    J Natl Cancer Inst, 98(4): 245-54. [Abstract] [Full-text]
  18. EGFR signaling pathway negatively regulates PSA expression and secretion via the PI3K-Akt pathway in LNCaP prostate cancer cells.
    Biochem Biophys Res Commun, 342(1): 92-100. [Abstract] [Full-text]
  19. Inactivation of Id-1 in prostate cancer cells: A potential therapeutic target in inducing chemosensitization to taxol through activation of JNK pathway.
    Int J Cancer, 118(8): 2072-81. [Abstract] [Full-text]
  20. Inhibitory effects of retinoic acid metabolism blocking agents (RAMBAs) on the growth of human prostate cancer cells and LNCaP prostate tumour xenografts in SCID mice.
    Br J Cancer, 94(4): 513-23. [Abstract] [Full-text]
  21. The feasibility and results of a population-based approach to evaluating prostate-specific antigen screening for prostate cancer in men with a raised familial risk.
    Br J Cancer, 94(4): 499-506. [Abstract] [Full-text]
  22. Feasibility of familial PSA screening: psychosocial issues and screening adherence.
    Br J Cancer, 94(4): 507-12. [Abstract] [Full-text]
  23. E-cadherin polymorphisms and haplotypes influence risk for prostate cancer.
    Prostate, 66(5): 546-56. [Abstract] [Full-text]
  24. PAC1-R null isoform expression in human prostate cancer tissue.
    Prostate, 66(5): 514-21. [Abstract] [Full-text]
  25. Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma.
    Prostate, 66(5): 503-13. [Abstract] [Full-text]
  26. Enhancement of intermittent androgen ablation by "off-cycle" maintenance with finasteride in LNCaP prostate cancer xenograft model.
    Prostate, 66(5): 495-502. [Abstract] [Full-text]
  27. Prostatic fluid concentrations of isoflavonoids in soy consumers are sufficient to inhibit growth of benign and malignant prostatic epithelial cells in vitro.
    Prostate, 66(5): 557-66. [Abstract] [Full-text]
  28. Murine androgen-independent neuroendocrine carcinoma promotes metastasis of human prostate cancer cell line LNCaP.
    Prostate, 66(5): 536-45. [Abstract] [Full-text]
  29. Gene therapy for prostate cancer: current strategies and new cell-based approaches.
    Prostate, 66(5): 470-94. [Abstract] [Full-text]
  30. Synthetic dimer of indole-3-carbinol: second generation diet derived anti-cancer agent in hormone sensitive prostate cancer.
    Prostate, 66(5): 453-62. [Abstract] [Full-text]
  31. Expression of prothymosin alpha is correlated with development and progression in human prostate cancers.
    Prostate, 66(5): 463-9. [Abstract] [Full-text]
  32. Serum hepatocyte growth factor activator inhibitor type I (HAI-I) and type 2 (HAI-2) in prostate cancer.
    Prostate, 66(5): 447-52. [Abstract] [Full-text]
  33. Prognostic significance of osteopontin expression in human prostate cancer.
    Int J Cancer, 118(9): 2255-61. [Abstract] [Full-text]
  34. A prostate secretory protein94-derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: implication in tumor angiogenesis.
    Int J Cancer, 118(9): 2350-8. [Abstract] [Full-text]
  35. Steroid hormones stimulate human prostate cancer progression and metastasis.
    Int J Cancer, 118(9): 2123-31. [Abstract] [Full-text]
  36. Management of prostate cancer. Part 1: chemoprevention.
    Expert Rev Anticancer Ther, 6(3): 419-25. [Abstract] [Full-text]
  37. Cluster model analysis of late rectal bleeding after IMRT of prostate cancer: a case-control study.
    Int J Radiat Oncol Biol Phys, 64(4): 1255-64. [Abstract] [Full-text]
  38. Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10.
    Int J Radiat Oncol Biol Phys, 64(4): 1162-7. [Abstract] [Full-text]
  39. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer.
    Int J Radiat Oncol Biol Phys, 64(4): 1151-61. [Abstract] [Full-text]
  40. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix.
    Life Sci, 78(16): 1784-93. [Abstract] [Full-text]
  41. PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis.
    Int J Radiat Oncol Biol Phys, 64(4): 1140-50. [Abstract] [Full-text]
Place a permanent text-link or advertisement here.

© 2004-2013 Prostate Cancer Research Today. All Rights Reserved.



Prostate Cancer Research Today Archive:

Volume 1 (2004)
  Issue 1 (August)
  Issue 2 (September)
  Issue 3 (October)
  Issue 4 (November)
  Issue 5 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 6 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 7 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 8 (2011)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 9 (2012)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 10 (2013)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)



Prostate Cancer Books

What Your Doctor May Not Tell You About(TM) Prostate Cancer: The Breakthrough Information and Treatments That Can Help Save Your Life (What Your Doctor May Not Tell You About...)

What Your Doctor May Not Tell You About(TM) Prostate Cancer: The Breakthrough Information and Treatments That Can Help Save Your Life (What Your Doctor May Not Tell You About...)